08/22/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
4:07 PM | Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
7:00 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
6:27 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
5:13 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:46 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
3:37 PM | Gyre Therapeutics (Filer)
| Form 424B5 | |
05/22/2025
4:27 PM | Gyre Therapeutics (Filer)
| Form 424B5 | |
05/14/2025
7:21 PM | Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:30 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for GYRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/22/2025
12:44 PM | Gyre Therapeutics (Filer)
| Form ARS | |
04/21/2025
4:23 PM | Gyre Therapeutics (Filer)
| Form DEF 14A | |
04/21/2025
4:23 PM | Gyre Therapeutics (Filer)
| Form DEFA14A | |
03/20/2025
3:01 PM | Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/17/2025
3:15 PM | Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2025
7:00 PM | Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:02 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:01 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
7:45 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:05 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:06 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Gyre Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:05 PM | Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
7:45 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
7:31 AM | Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
| Form SC 13D | |
09/06/2024
7:15 AM | Gyre Therapeutics (Subject)
Luo Ying (Filed by)
| Form SC 13D | |
MarketBeat All Access